Adam D. Cohen, MD, is the Director of Myeloma Immunotherapy, Amyloidosis Program Co-Director, and Associate Professor of Medicine at the Abramson Cancer Center at the University of Pennsylvania. His research focuses on clinical development of novel therapies, particularly immunotherapies, for patients with myeloma, AL amyloidosis and other plasma cell dyscrasias. Dr Cohen's attendance is kindly sponsored by Janssen